CAPABILITIES

We are fully integrated and fully dedicated

Our competencies run deep: from our strong in-house R&D to our sales & marketing, we are poised to provide critical care therapeutic solutions and support for years to come.

 

Learn more about our areas of expertise by clicking on each capability.

 

References
  1. Agency for Toxic Substances and Disease Registry. Toxicological profile for hydrogen sulfide. Atlanta, GA: US Department of Health and Human Services; 2006. CAS 7783-06-4.
  2. Blakemore C, Jennett S. Nitric oxide. Encyclopedia.com Web site. http://www.encyclopedia.com/printable.aspx?id=10128.nitricoxide. Accessed May 27, 2009.
  3. INOMAX [package insert]. Clinton, NJ: INO Therapeutics LLC; 2007.
  4. Lee DC, Ferguson KL. Methemoglobinemia. eMedicine Web site. http://emedicine.medscape.com/article/815613-overview. Accessed May 29, 2009.
  5. Kuhl SJ, Rosen H. Nitric oxide and septic shock: from bench to bedside. West J Med. 1998;168(3):176–181.  
  6. Westphal M, Rehberg S, Ertmer C, Morelli A. Terlipressin -- more than just a prodrug of lysine vasopressin? Crit Care Med. 2009;37(3):1135-1136.
  7. Landa N, Miller L, Feinberg MS, et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation. 2008;117(11):1388-1396.